BRADLEY SHAW: Open Payments
NPI 1942721592 · CLEARFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 40 payments from 9 companies in 2025. Trend: 2023 $732 · 2024 $801 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $318 |
| Collegium Pharmaceutical, Inc. | 8 | $138 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Lundbeck LLC | 3 | $57 |
| Novo Nordisk Inc | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Alkermes, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, Jornay PM, QULIPTA, Qelbree, REXULTI, UBRELVY, CAPLYTA, Wegovy.
Industry payments across PA — which companies pay providers there.
